Cian Healthcare Stock Screener | Share Price & Fundamental Analysis

CHCL Pharmaceuticals
Screen Cian Healthcare share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap ₹12.73 Cr.
P/E Ratio (TTM) -
P/B Ratio 0.39
EPS (TTM) ₹-10.39
Dividend Yield -
Debt to Equity 1.22
52W High -
52W Low -
Operating Margin -
Profit Margin -
Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹156.00
Total Equity ₹32.00
Last updated: Jan 10, 2026

Cian Healthcare Share Price History - Stock Screener Chart

Screen CHCL historical share price movements with interactive charts. Analyze price trends and patterns.

Cian Healthcare Company Profile - Fundamental Screener

Screen Cian Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CHCL shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE05BN01019

Cian Healthcare Balance Sheet Screener - Fundamental Analysis

Fair Value Analysis
Screen CHCL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020
Assets
Total Assets 156 161 161 166 157 157
Current Assets 71 72 74 79 63 54
Fixed Assets 35 39 45 50 37 39
Liabilities
Total Liabilities 156 161 161 166 157 157
Current Liabilities 9 37 38 41 41 50
Non-Current Liabilities 0 0 0 0 0 0
Shareholders' Equity
Total Equity 32 58 58 56 58 58
Share Capital 25 25 25 25 23 23
Reserves & Surplus 7 33 33 31 35 35

Cian Healthcare Income Statement Screener - Profit & Revenue Analysis

Intrinsic Value
Screen CHCL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March
Revenue 0 31 62 69 78 74 58
Expenses 0 38 51 56 74 62 50
EBITDA 0 -6 11 13 5 12 8
Operating Profit % 0.00% -22.00% 18.00% 18.00% 5.00% 16.00% 13.00%
Depreciation 0 4 6 5 4 4 4
Interest 0 3 6 6 6 8 7
Profit Before Tax 0 -26 0 2 -6 1 -4
Tax 0 0 -1 0 -1 1 0
Net Profit 0 -26 1 2 -6 0 -4
EPS 0.00 -10.39 0.34 0.81 -2.21 0.02 -1.62

Cian Healthcare Cash Flow Screener - Liquidity Fundamentals

Screen CHCL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March
Operating Activities 21 12 5 9 6 -7
Investing Activities 0 -2 3 1 3 -27
Financing Activities -4 -10 -7 -11 -10 36
Net Cash Flow 17 0 0 -1 -1 1

Cian Healthcare Shareholding Pattern Screener - Ownership Analysis

Screen CHCL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
Item 2025-Sept 2025-Mar 2024-Sept 2024-Jun 2024-Mar 2023-Sept 2023-Mar 2022-Dec
Promoter Holding 27.10% 27.10% 27.10% 27.10% 27.10% 49.62% 51.85% 66.26%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.79%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 63.77% 63.56% 59.23% 56.59% 55.78% 41.08% 41.88% 24.00%
Other Holding 9.12% 9.34% 13.67% 16.31% 17.12% 9.30% 6.27% 8.95%
Shareholder Count 1,662 1,501 1,088 831 880 672 454 418

Cian Healthcare Dividend Screener - Share Yield Analysis

Screen CHCL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
No dividends declared by Cian Healthcare.

Cian Healthcare Index Membership - Market Screener Classification

Screen CHCL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Cian Healthcare is not part of any tracked indices.
Only major market indices are tracked in our system.

Cian Healthcare Market Events Screener - Corporate Actions

Screen CHCL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
Announcement Date Record Date Event Type Information Price Impact
2025-12-17 2025-12-17 Annual General Meeting NA -17.61%
2024-10-08 2024-10-08 Annual General Meeting NA -9.16%

Cian Healthcare Competitors Screener - Peer Comparison

Screen CHCL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 416,764 40.16 54,729 9.71% 10,980 41.99
Divis Laboratories 172,462 69.16 9,712 18.67% 2,191 54.95
Torrent Pharmaceuticals 129,770 60.40 11,539 6.99% 1,911 64.03
Cipla 120,864 22.30 28,410 7.12% 5,291 43.36
Dr Reddys Laboratories 105,645 18.66 33,741 16.73% 5,725 50.22
Lupin 96,238 22.21 22,910 13.74% 3,306 58.72
Zydus Life Science 92,352 18.57 23,511 18.55% 4,615 41.66
Mankind Pharma 90,530 51.90 12,744 20.90% 2,007 47.28
Aurobindo Pharma 70,358 20.66 32,346 9.43% 3,484 55.09
Alkem Laboratories 66,550 27.75 13,458 3.70% 2,216 44.89

Cian Healthcare Company Announcements - News Screener

Screen CHCL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) View
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer View
Announcement under Regulation 30 (LODR)-Resignation of Director View
Announcement under Regulation 30 (LODR)-Resignation of Managing Director View
Announcement under Regulation 30 (LODR)-Change in Management View
Board Meeting Outcome for Outcome Of The First Meeting (CIAN/RPIC/2025-26/01) Of The Resolution Plan Implementation Committee (Implementation Committee) Held On December 24 2025. View
2026-01-07 Constitution Of The Resolution Plan Implementation Committee Of Cian Healthcare Limited Pursuant To The Approval Of The Resolution Plan By The Honble NCLT. View
2026-01-05 Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal View
2026-01-04 Announcement under Regulation 30 (LODR)-Change in Management View
2026-01-04 Summary Of Proceedings Of The 22Nd Annual General Meeting Of The Company Held On December 17 2025. View
2026-01-04 Shareholder Meeting / Postal Ballot-Scrutinizers Report View
2026-01-04 Shareholder Meeting / Postal Ballot-Outcome of AGM View
2025-11-29 Clarification Regarding Extension Of Annual General Meeting (AGM) Of Cian Healthcare Limited (Company). View
2025-11-27 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-11-25 Corrigendum To The Notice Of 22Nd Annual General Meeting ("AGM") Of The Company Scheduled To Be Held On Wednesday December 17 2025 At 10:00 A.M. Through Video Conferencing/Other Audio-Visual Means. View
2025-11-25 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-11-24 Reg. 34 (1) Annual Report. View
2025-11-24 Notice Of The 22Nd (Twenty-Second) Annual General Meeting Of The Members Of Cian Healthcare Limited Scheduled To Be Held On Wednesday December 17 2025 At 10:00 A.M. Through Video Conference /Other Audio-Visual Means ("VC / OAVM"). View
2025-11-22 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2025-11-21 Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 By Cian Healthcare Limited (Company) View
Back to Screener